Market revenue in 2023 | USD 6.3 million |
Market revenue in 2030 | USD 49.8 million |
Growth rate | 34.3% (CAGR from 2023 to 2030) |
Largest segment | Dogs |
Fastest growing segment | Cats |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dogs, Cats |
Key market players worldwide | Petco Health and Wellness Co Inc Ordinary Shares - Class A, Charlottes Web Holdings Inc Ordinary Shares, Woolworths Group Ltd, SNDL Inc Ordinary Shares, Honest Paws, Canna-Pet, Green Roads, Pet Releaf, Holistapet, Joy Organics, Wet Noses, CBD Living, Hemp My Pet |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cbd pet market will help companies and investors design strategic landscapes.
Dogs was the largest segment with a revenue share of 65.08% in 2023. Horizon Databook has segmented the Australia cbd pet market based on dogs, cats covering the revenue growth of each sub-segment from 2018 to 2030.
The use of CBD for pets is on the rise in Australia's expanding medicinal cannabis market. The country has plans to cultivate, market, and export CBD to meet the growing demand. CBD is gaining popularity as a treatment for pet health issues as part of a comprehensive approach to managing chronic illnesses.
As long as they have received approval from the Australian Register of Therapeutic Goods (ARTG), products with small amounts of CBD are considered safe and legal. Moreover, according to INN report, on February 1, 2021, purchasing low-dose CBD products from pharmacies was officially legal.
This modification marked a reclassification of CBD by Australia's Therapeutic Goods Administration; it was moved from Schedule 4 (prescription medicine) to Schedule 3 (nonprescription medicine) (pharmacist-only medicine).
Horizon Databook provides a detailed overview of country-level data and insights on the Australia cbd pet market , including forecasts for subscribers. This country databook contains high-level insights into Australia cbd pet market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account